New Insight Into Off-Label Ketamine Use for Depression By Nancy A. Melville MIAMI – As the off-label use of ketamine for the treatment of severe depression continues to soar, two new studies provide insight into the way clinicians are using it in the field, away from the research setting. In [...]
SAN DIEGO, May 20, 2017 – Cyberbullying may exacerbate mental health conditions among adolescents, particularly teens who have experienced previous emotional abuse, according to new research presented at the Annual Meeting of the American Psychiatric Association in San Diego. Cyberbullying is a common experience among adolescents and has received [...]
The Achilles Heel of psychiatry has always been the public's distrust of what defines a mental disorder and whether it can be treated effectively. Oftentimes, not until a trusted public person speaks up about his or her battle with a mental disorder does the public, in turn, accept the disease [...]
Deep brain stimulation, an established therapy that modifies the brain's circuitry to treat symptoms of depression, Parkinson's disease and other movement disorders, is attracting fresh attention from medical-device makers who believe it is underused. St. Jude Medical Inc. recently introduced a new DBS system in the U.S., and Boston Scientific [...]
Researchers have identified six regions of the human genome that are significantly linked to personality traits, and some show significant correlations to certain psychiatric disorders as well. The study, conducted by researchers at the University of California San Diego School of Medicine, is based on a meta-analysis of genome-wide association [...]
Original Investigation ABSTRACT Importance Despite recent increased use of antidepressants in the United States, concerns persist that many adults with depression do not receive treatment, whereas others receive treatments that do not match their level of illness severity. Objective To characterize the treatment of adult depression in the United States. [...]
Is Special K the Anti-Depressant We’ve Waited For? A groundbreaking study on the popular club drug shows its massive potential in treating depression, with a ketamine spray coming to market as soon as 2019. According to The Daily Beast, infamous pharma bro Martin Shkreli’s company Turing Pharmaceuticals recently inked a $95 [...]
Other than the obvious onset of the mental disorder itself, postpartum depression is one of those illnesses that is hard to predict, and according to published records, may be even harder to insure against. After a government panel recommended that pregnant women be screened for depression, life and disability insurance [...]
Early Intervention for Psychotic Disorders: Building Population Health Systems This Viewpoint proposes a conceptual framework for population health systems that would enable early intervention services for patients with new-onset psychotic disorders. Treatment works; the earlier, the better. The intuition that, if applied early in the course of illness, available treatments for [...]
What’s Included: • Hamilton Rating Scale for Depression • Montgomery-Asberg Depression Rating Scale